FDA Inspection 1241666 — Wojciech Jurczak, MD., PhD.
The FDA completed an inspection of Wojciech Jurczak, MD., PhD. on May 9, 2024 in Cracow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cracow (Poland)
Additional Details
Clinical Investigator (CI)